An honest discussion of vaginoplasty complications is part of good surgical care, not a reason to avoid surgery. Patients who understand the risk profile before they consent are better prepared, more likely to recognise problems early, and consistently report higher satisfaction with their overall experience, even in cases where a complication did occur.
This guide covers the full complication landscape for gender-affirming vaginoplasty: what types of complications occur, how often, what warning signs to watch for, and how the combination of an accredited hospital environment, an experienced surgical team, and structured post-operative support manages them. It is written to give you accurate, clinical information, not to alarm or reassure you falsely.
For a full overview of the procedure itself, see our complete guide to sex reassignment surgery in Thailand. For the broader picture of institutional safety, including what JCI accreditation means and how Bangkok hospitals compare to Western counterparts, see our article on whether SRS surgery in Thailand is safe.
Understanding the Numbers: What Complication Rates Really Mean
If you search the literature on vaginoplasty, you will encounter figures that can seem alarming at first glance. A 2024 review in Current Opinion in Urology noted that “complication rates have been documented as high as 70%.” A 2023 retrospective analysis found a complication rate of 46.3% at 30 days, rising to 79.6% at 90 days.
Those numbers are accurate, but the framing matters enormously. Most complications captured in these figures are classified as Clavien-Dindo Grade I or II, the two lowest tiers of the internationally recognised surgical complication grading system. Grade I complications are deviations from the expected recovery course that need only supportive care, wound dressings, pain relief, and rest. Grade II complications require medication such as antibiotics or antifungals. At a high-volume, JCI-accredited hospital, neither category typically disrupts a patient’s overall outcome.
The most common complications at 30 and 90 days are yeast infection, granulation tissue, and haematoma. All are manageable. The same review notes that these complications “are generally minor and easily treatable with antibiotics, silver nitrate, and surgical evacuation.” What the headline rates capture is the full range of anything that deviated from a textbook recovery course, including a yeast infection that resolved in a week with medication.
The key distinction is between complication rate and serious complication rate. Across the literature, Grade III or above complications and those requiring surgical intervention are far less common than the headline rates suggest. Patients with a clear sense of this distinction are better placed to evaluate risk honestly.
Complications at a Glance
The table below maps vaginoplasty complications by timing, incidence from published data, management approach, and Clavien-Dindo grade. Incidence data draws primarily on Hontscharuk et al. (Andrology, 2021) and the Mount Sinai systematic review of vaginal stenosis (Urology, 2024), both peer-reviewed and drawing on large multi-study cohorts. *Clavien-Dindo Grade I = supportive care only; Grade II = medication required; Grade III = surgical intervention; Grade IV = life-threatening. Row shading: white/grey = common and typically minor; amber = moderate; red = serious but rare.
| Complication | Timing | Incidence | How managed | Severity* |
| Granulation tissue | Weeks 4-12 | Very common | Silver nitrate application in clinic | Grade I |
| Yeast / fungal infection | Weeks 1-12 | Common | Antifungal medication | Grade I-II |
| Urinary tract infection | Weeks 1-8 | Common | Antibiotics | Grade I-II |
| Wound dehiscence (minor) | Weeks 1-6 | 3%-33% | Wound care, observation, time | Grade I-II |
| Haematoma | Days 1-14 | 1.6%-21% | Most resolve; some need drainage | Grade I-III |
| Wound infection | Weeks 1-4 | Reported up to 10% | Antibiotics; debridement if needed | Grade I-II |
| Voiding difficulty | Days 1-14 | Variable | Catheter management; urological review | Grade I-II |
| Vaginal stenosis | Months 3+ | 5.83% overall (PIV 5.70%) | Dilation intensification; surgical revision if severe | Grade I-III |
| Introital stenosis | Months 1-6 | Included in 9.68% cumulative VS rate | Dilation; minor surgical revision | Grade I-III |
| Depth reduction | Months 3+ | Dilation-related; variable | Dilation protocol review; revision in some cases | Grade I-III |
| Rectovaginal fistula | Days-weeks | ~1% (pooled data) | Surgical repair; colostomy in complex cases | Grade III |
| Clitoral sensitivity loss | Post-op | Low at high-volume centres | Surgical technique; nerve monitoring | Grade III |
| DVT / pulmonary embolism | Days 1-28 | Low; risk managed pre-op | Anticoagulation; compression; mobilisation protocol | Grade IV |
The Most Common Complications and How They Are Resolved
Granulation Tissue
Granulation tissue is the most frequently documented complication after vaginoplasty and is a normal part of how the body responds to surgical wounds in certain sites. It appears as small, raised, pink or red areas around the vaginal opening or at suture lines. Left untreated, it can cause minor bleeding or discomfort; treated, it resolves quickly. The standard treatment is silver nitrate application in a clinical setting, a brief, straightforward outpatient procedure that most patients find manageable. It is not a sign that something has gone seriously wrong.
Wound Dehiscence and Healing Delays
Wound separation (dehiscence) at suture lines, particularly around the labia or introitus, is documented in 3% to 33% of patients, depending on how strictly it is defined. Minor dehiscence in the first weeks is generally managed conservatively: keeping the area clean, following wound care instructions, and allowing the tissue to re-epithelialise at its own pace. Factors that increase wound healing risk include smoking, poor diabetes control, and elevated BMI, all of which are assessed and where possible optimised before surgery.
Haematoma and Bleeding
Post-operative haematoma, blood pooling in the surgical site, occurs in 1.6% to 21% of patients, depending on definition and measurement. The majority resolve without intervention. Some require drainage, which is a straightforward procedure carried out at the hospital. Significant intraoperative bleeding requiring transfusion occurs in under 5% of patients at experienced centres. A haematoma that develops after discharge and does not respond to conservative measures is a reason to contact your surgical team promptly.
Infection
Superficial wound infection, urinary tract infection, and fungal (yeast) overgrowth are all common in the post-operative period and respond well to the appropriate antimicrobials. Fungal infections are particularly common due to the combination of antibiotics used peri-operatively and the moist post-surgical environment. A course of antifungal medication resolves them within days to weeks. Serious infections requiring intravenous antibiotics or surgical debridement are less common and are managed within the hospital environment.
Vaginal Stenosis
Vaginal stenosis is the most clinically significant late complication and the one most directly within the patient’s influence. A systematic review of 59 studies covering 7,338 patients (Urology, 2024) found an overall vaginal stenosis incidence of 5.83%, with the rate for penile inversion vaginoplasty specifically at 5.70%. Combined with introital stenosis, the cumulative incidence was 9.68%.
Stenosis is caused by inadequate or inconsistent dilation during the healing period. For the majority of patients whose stenosis is detected early, the first-line management is intensive dilation, increasing frequency, revisiting technique, and addressing pelvic floor tension that may be making dilation ineffective. Surgical revision is reserved for cases where dilation has failed to maintain adequate calibre. This is why dilation adherence is not optional: it is the primary patient-controllable variable in preventing the most common serious late complication.
Serious Complications: Rare but Clinically Important
Rectovaginal Fistula
A rectovaginal fistula is an abnormal connection between the neovaginal canal and the rectum. Pooled data from a systematic review place the incidence at approximately 1%. It is a serious complication requiring surgical repair and is more common with the penile inversion technique than sigmoid colon vaginoplasty. At high-volume specialist centres, risk mitigation includes meticulous intraoperative technique, bowel preparation before surgery, and careful dissection of the rectovaginal plane. Patients who develop symptoms, passage of gas or faecal material from the vaginal opening, or unexplained infection should contact their surgical team immediately. Management typically requires staged surgical repair.
Clitoral Sensitivity Loss or Necrosis
The neoclitoris is created from the glans of the penis with its neurovascular bundle preserved. At experienced centres, clinically significant loss of clitoral sensitivity is uncommon. Clitoral necrosis, which can occur if the blood supply to the neoclitoris is compromised during or after surgery, is rare. Prevention is primarily a surgical technique issue; it is one reason surgeon volume and technique matter. Patients who notice darkening, unusual swelling, or significant pain of the neoclitoris in the immediate post-operative period should alert the nursing team without delay.
DVT and Thromboembolic Events
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are rare but serious anaesthetic and post-operative risks for any major elective procedure. Oestrogen therapy is itself a mild pro-thrombotic factor, which is why the pre-surgical hormone pause is standard practice. Intraoperatively, compression boots and careful positioning reduce DVT risk. Post-operatively, early mobilisation, compression stockings, and anticoagulation, where clinically indicated, are the management approaches. Medidash advises on fit-to-fly protocol for the return journey, since long-haul flights represent an additional DVT risk in the early post-operative period.
Serious complications such as rectovaginal fistula, clitoral necrosis, and thromboembolic events are the cases that give vaginoplasty its reputation as a complex procedure. They occur. Their rarity at high-volume accredited centres reflects the quality of surgical technique, institutional protocols, and patient selection, not an absence of risk.
Warning Signs: When to Contact Your Surgical Team
Patients who know what to look for are patients who can act early. The following symptoms should prompt immediate contact with your care team, not a wait-and-see approach.
- Fever above 38.5°C (101.3°F) at any point during the first four weeks after surgery
- Significant or worsening swelling, redness, or warmth around the surgical site that was not present the day before
- Foul-smelling discharge from the vaginal opening, wound site, or urethra
- Passage of gas or faecal matter from the vaginal opening (possible sign of rectovaginal fistula)
- Unusual darkening, hardness, or extreme pain at the neoclitoris in the first 10 days after surgery
- Significant bleeding from the surgical site, especially soaking dressings or filling the toilet bowl
- Unable to pass urine after catheter removal
- Dilation becoming progressively harder over several consecutive days (possible early stenosis)
- Calf pain, swelling or redness combined with breathlessness or chest pain (possible DVT/PE, call emergency services)
How Accredited Hospitals Reduce Complication Risk
The data make clear that complication rates at high-volume gender-affirming surgery centres are substantially lower than population-level aggregate figures suggest. Several factors drive this:
- Surgical volume: surgeons performing hundreds of procedures annually develop refined tissue handling that directly reduces intraoperative risk, especially for complex steps like rectovaginal plane dissection and neurovascular bundle preservation
- JCI-accredited infection control: theatre sterility, antibiotic prophylaxis protocols, nursing hygiene standards, and wound care guidelines are all independently audited
- Pre-operative patient optimisation: smoking cessation, diabetes control, BMI review, hormone pause, and hair removal compliance reduce modifiable risk before the first incision
- Immediate in-hospital monitoring: the 4-to-7-day hospital stay at Phyathai 2 provides structured nursing observation, early problem identification, and same-day clinical access if a complication develops
- Structured dilation training before discharge: starting dilation in the hospital with nursing guidance reduces the rate of early stenosis caused by incorrect technique or missed sessions
How Medidash Supports Patients When Complications Arise
Medidash provides 12 months of post-operative support for all patients, not because complications are expected, but because when they do arise, having a single point of contact who knows your case, your hospital, and your surgical team is a material advantage.
What that looks like in practice: if a patient in London develops increasing difficulty with dilation three months after returning home, Medidash can facilitate a remote consultation with the surgical team, provide guidance on whether escalation is needed, and help navigate the connection between the Bangkok surgeon and the patient’s local GP. If a complication requires a return visit, Medidash coordinates that process. If a patient simply has a question at six months about whether a symptom is normal, Medidash is the first call.
International patients who manage their recovery without this kind of support are not in a worse clinical position, but they are in a worse navigational one. They are interpreting symptoms without context, making judgment calls without someone who knows their specific situation, and searching forums instead of talking to their care team. Medidash exists to close that gap. To discuss what 12-month support looks like for your situation, get in touch with the Medidash team.
Putting the Risk Profile in Context
Vaginoplasty is a complex reconstructive procedure and carries a genuine risk of complications. That statement should be in every pre-operative conversation. So should the following: adverse events following vaginoplasty are “commensurate with other genitourinary reconstructive procedures performed for other diagnoses such as cancer or congenital issues,” as noted in the Andrology 2021 systematic review. The procedure is not uniquely risky compared to other major genital reconstruction surgeries. It is performed to manage a clinically recognised and significant condition. And it is associated with rates of satisfaction, quality of life improvement, and regret as low as 1% that are matched by very few surgical interventions in any specialty.
Understanding the complications is part of understanding the procedure fully. For patients who have reviewed this material and want to understand the pathway to surgery, including what to expect at every stage from initial consultation through recovery, see our complete guide to MTF bottom surgery. For the recovery picture, including dilation protocol, see vaginoplasty recovery: what to expect.